$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2017-08-28 AccNo: 0001104659-17-054012 Size: 45 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of 网页链接